Artwork

Το περιεχόμενο παρέχεται από το Rick Da Don. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Rick Da Don ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
Player FM - Εφαρμογή podcast
Πηγαίνετε εκτός σύνδεσης με την εφαρμογή Player FM !

Is Synaptogenix, Inc. Worth Investing In | Penny Stock Analysis

15:55
 
Μοίρασέ το
 

Manage episode 378031147 series 3475815
Το περιεχόμενο παρέχεται από το Rick Da Don. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Rick Da Don ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

Full Playlist: https://youtube.com/playlist?list=PLGvBbL_es1xo3Oly9nksjk0qrdwA2Fia9

Becoming Ritchie Rich is a new show that takes a deep dive into various penny stocks. If you are someone who wants to learn about the stock market or trades penny stocks, this show is for you. Join me as we do some deep analysis of a popular penny stock. Feel free to ask questions, give suggestions, and share penny stocks you'd like me to take a look at next. Today's popular penny stock is Synaptogenix (SNPX).

Weerdy:

https://Weerdy.com

SNPX Stock:

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer’s disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.

SNPX Financial Summary:

Synaptogenix, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 4.09 million compared to USD 3.75 million a year ago. Basic loss per share from continuing operations was USD 1.39 compared to USD 0.54 a year ago. Diluted loss per share from continuing operations was USD 1.39 compared to USD 0.54 a year ago.For the six months, net loss was USD 5.81 million compared to USD 7.03 million a year ago. Basic loss per share from continuing operations was USD 1.66 compared to USD 1.01 a year ago. Diluted loss per share from continuing operations was USD 1.66 compared to USD 1.01 a year ago.

About the Host:

Ritchie "Rick Da Don" Knox is a serial entrepreneur, investor, media personality, musician, artist, and philanthropist from Detroit, Michigan (USA).

Disclaimer:

Becoming Ritchie Rich's host Ritchie Rich is not a financial advisor. This show is created purely for entertainment purposes. Before buying into any position, please DO YOUR OWN RESEARCH.

#Investing #investinginmyfuture #investinginmyself #InvestingInRealEstate #investinginme #investingbooks #investingquotes #investingeducation #investingforus #investinginyourself #InvestInGold #investingstrategy #investinginyourhealth #investinginthefuture #investingwordsofwisdom #investinginyourpeople #investingtips #investingwithjg #investingplanning #Investingnetworkclub #INVESTINGINHISTORY #investingabroad #investinghana #investinginhumanpotential #investingday #InvestingForU #investingourself #investingforwealth #investingolnetworkmarketing #investingnoob

Thanks for LIKING, SHARING, and COMMENTING on this video!

  continue reading

132 επεισόδια

Artwork
iconΜοίρασέ το
 
Manage episode 378031147 series 3475815
Το περιεχόμενο παρέχεται από το Rick Da Don. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Rick Da Don ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

Full Playlist: https://youtube.com/playlist?list=PLGvBbL_es1xo3Oly9nksjk0qrdwA2Fia9

Becoming Ritchie Rich is a new show that takes a deep dive into various penny stocks. If you are someone who wants to learn about the stock market or trades penny stocks, this show is for you. Join me as we do some deep analysis of a popular penny stock. Feel free to ask questions, give suggestions, and share penny stocks you'd like me to take a look at next. Today's popular penny stock is Synaptogenix (SNPX).

Weerdy:

https://Weerdy.com

SNPX Stock:

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer’s disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.

SNPX Financial Summary:

Synaptogenix, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 4.09 million compared to USD 3.75 million a year ago. Basic loss per share from continuing operations was USD 1.39 compared to USD 0.54 a year ago. Diluted loss per share from continuing operations was USD 1.39 compared to USD 0.54 a year ago.For the six months, net loss was USD 5.81 million compared to USD 7.03 million a year ago. Basic loss per share from continuing operations was USD 1.66 compared to USD 1.01 a year ago. Diluted loss per share from continuing operations was USD 1.66 compared to USD 1.01 a year ago.

About the Host:

Ritchie "Rick Da Don" Knox is a serial entrepreneur, investor, media personality, musician, artist, and philanthropist from Detroit, Michigan (USA).

Disclaimer:

Becoming Ritchie Rich's host Ritchie Rich is not a financial advisor. This show is created purely for entertainment purposes. Before buying into any position, please DO YOUR OWN RESEARCH.

#Investing #investinginmyfuture #investinginmyself #InvestingInRealEstate #investinginme #investingbooks #investingquotes #investingeducation #investingforus #investinginyourself #InvestInGold #investingstrategy #investinginyourhealth #investinginthefuture #investingwordsofwisdom #investinginyourpeople #investingtips #investingwithjg #investingplanning #Investingnetworkclub #INVESTINGINHISTORY #investingabroad #investinghana #investinginhumanpotential #investingday #InvestingForU #investingourself #investingforwealth #investingolnetworkmarketing #investingnoob

Thanks for LIKING, SHARING, and COMMENTING on this video!

  continue reading

132 επεισόδια

Όλα τα επεισόδια

×
 
Loading …

Καλώς ήλθατε στο Player FM!

Το FM Player σαρώνει τον ιστό για podcasts υψηλής ποιότητας για να απολαύσετε αυτή τη στιγμή. Είναι η καλύτερη εφαρμογή podcast και λειτουργεί σε Android, iPhone και στον ιστό. Εγγραφή για συγχρονισμό συνδρομών σε όλες τις συσκευές.

 

Οδηγός γρήγορης αναφοράς